Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Yuan, Junying

Class:IdPerson:3791099
_displayNameYuan, Junying
_timestamp2013-07-04 22:07:54
created[InstanceEdit:3791108] May, B, 2013-07-04
firstnameJunying
initialJ
surnameYuan
(author)[LiteratureReference:3791116] Dual role of sumoylation in the nuclear localization and transcriptional activation of NFAT1
[LiteratureReference:5621041] Identification of RIP1 kinase as a specific cellular target of necrostatins
[LiteratureReference:5621054] Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
[LiteratureReference:5643926] Expansion and evolution of cell death programmes
[LiteratureReference:5691438] Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity
[LiteratureReference:6781949] Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13
[LiteratureReference:6810384] The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor
[LiteratureReference:8863194] G-protein-coupled receptors regulate autophagy by ZBTB16-mediated ubiquitination and proteasomal degradation of Atg14L
[LiteratureReference:9679817] Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1
[LiteratureReference:9685668] Targeting RIPK1 for the treatment of human diseases
List all 26 refering instances
[Change default viewing format]
No pathways have been reviewed or authored by Yuan, Junying (3791099)